{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:01:38Z","timestamp":1790416898428,"version":"4.1.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T00:00:00Z","timestamp":1501718400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s12264-017-0159-5","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T03:12:22Z","timestamp":1501729942000},"page":"526-534","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Premotor Diagnosis of Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"33","author":[{"given":"Heinz","family":"Reichmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,3]]},"reference":[{"key":"159_CR1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00415-009-5243-y","volume":"256","author":"KA Jellinger","year":"2009","unstructured":"Jellinger K A. Formation and development of Lewy pathology: a critical update. J Neurol 2009, 256: 270\u2013279.","journal-title":"J Neurol"},{"key":"159_CR2","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 1997, 276: 2045\u20132047.","journal-title":"Science"},{"key":"159_CR3","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.bbamem.2016.03.012","volume":"1858","author":"A West","year":"2016","unstructured":"West A, Brummel BE, Braun AR, Rhoades E, Sachs JN. Membrane remodeling and mechanics: Experiments and simulations of a-synuclein. Biochim Biophys Acta 2016, 1858: 1594\u20131609.","journal-title":"Biochim Biophys Acta"},{"key":"159_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-7091-6360-3_1","volume":"56","author":"KA Jellinger","year":"1999","unstructured":"Jellinger KA. Post mortem studies in Parkinson\u2019s disease-is it possible to detect brain areas for specific symptoms? J Neural Transm 1999, 56: 1\u201329.","journal-title":"J Neural Transm"},{"key":"159_CR5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Steur ENJ, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 2003, 24: 197\u2013211.","journal-title":"Neurobiol Aging"},{"key":"159_CR6","doi-asserted-by":"crossref","first-page":"e8762","DOI":"10.1371\/journal.pone.0008762","volume":"5","author":"F Pan-Montojo","year":"2010","unstructured":"Pan-Montojo F, Anichtchik O, Dening Y, Knels L, Pursche S, Jung R, et al. Progression of Parkinson\u2019s disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One 2010, 5: e8762.","journal-title":"PLoS One"},{"key":"159_CR7","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/srep00898","volume":"2","author":"F Pan-Montojo","year":"2012","unstructured":"Pan-Montojo F, Schwarz M, Winkler C, Arnhold M, O\u2019Sullivan GA, Pal A, et al. Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci Rep 2012, 2: 898\u2013904.","journal-title":"Sci Rep"},{"key":"159_CR8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ana.24448","volume":"78","author":"E Svensson","year":"2015","unstructured":"Svensson E, Horv\u00e1th-Puh\u00f3 E, Thomsen RW, Djurhuus JC, Pedersen L, Borghammer P, et al. Vagotomy and subsequent risk of Parkinson\u2019s disease. Ann Neurol 2015, 78: 522\u2013529.","journal-title":"Ann Neurol"},{"key":"159_CR9","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/ana.24531","volume":"78","author":"OB Tysnes","year":"2015","unstructured":"Tysnes OB, Kenborg L, Herlofson K, Steding-Jessen M, Horn A, Olsen JH, et al. Does vagotomy reduce the risk of Parkinson\u2019s disease? Ann Neurol 2015, 78: 1011\u20131012.","journal-title":"Ann Neurol"},{"key":"159_CR10","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.parkreldis.2008.12.005","volume":"15","author":"A Haehner","year":"2009","unstructured":"Haehner A, Boesveldt S, Berendse HW, Mackay-Sim A, Fleischmann J, Silburn PA, et al. Prevalence of smell loss in Parkinson\u2019s disease-A multicenter study. Parkinsonism Relat Disord 2009, 15: 490\u2013494.","journal-title":"Parkinsonism Relat Disord"},{"key":"159_CR11","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/mds.25844","volume":"29","author":"D Berg","year":"2014","unstructured":"Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, et al. Time to redefine PD? Introductory statement of the MDS task force on the definition of Parkinson\u2019s disease. Mov Disord 2014, 29: 454\u2013462.","journal-title":"Mov Disord"},{"key":"159_CR12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ana.21291","volume":"63","author":"GW Ross","year":"2008","unstructured":"Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, et al. Association of olfactory dysfunction with risk for future Parkinson\u2019s disease. Ann Neurol 2008, 63: 167\u2013173.","journal-title":"Ann Neurol"},{"key":"159_CR13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0021-9681(75)90058-2","volume":"28","author":"KA Ansari","year":"1975","unstructured":"Ansari KA, Johnson A. Olfactory function in patients with Parkinson\u2019s disease. J Chronic Dis 1975, 28: 493\u2013497.","journal-title":"J Chronic Dis"},{"key":"159_CR14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1212\/WNL.44.2.266","volume":"44","author":"MB Stern","year":"1994","unstructured":"Stern MB, Doty RL, Dotti M, Corcoran P, Crawford D, McKeown DA, et\u00a0al. Olfactory function in Parkinson\u2019s disease subtypes. Neurology 1994, 44: 266\u2013268.","journal-title":"Neurology"},{"key":"159_CR15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/jnnp.62.5.436","volume":"62","author":"CH Hawkes","year":"1997","unstructured":"Hawkes CH, Shephard BC, Daniel SE. Olfactory dysfunction in Parkinson\u2019s disease. J Neurol Neurosurg Psych 1997, 62: 436\u2013446.","journal-title":"J Neurol Neurosurg Psych"},{"key":"159_CR16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s001150050640","volume":"71","author":"RF Daum","year":"2000","unstructured":"Daum RF, Sekinger B, Kobal G, Lang C. Olfactory testing with \u201csniffin\u2019 sticks\u201d for clinical diagnosis of Parkinson disease. Nervenarzt 2000, 71: 643\u2013650.","journal-title":"Nervenarzt"},{"key":"159_CR17","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1212\/WNL.38.8.1237","volume":"38","author":"RL Doty","year":"1988","unstructured":"Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 1988, 38: 1237\u20131244.","journal-title":"Neurology"},{"key":"159_CR18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/chemse\/22.1.39","volume":"22","author":"T Hummel","year":"1997","unstructured":"Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. \u201cSniffin\u2019 sticks\u201d: olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 1997, 22: 39\u201352.","journal-title":"Chem Senses"},{"key":"159_CR19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00405-006-0173-0","volume":"264","author":"T Hummel","year":"2007","unstructured":"Hummel T, Kobal G, Gudziol H, Mackay-Sim A. Normative data for the \u201cSniffin`Sticks\u201d including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur Arch Otorhinolaryngol 2007, 264: 237\u2013243.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"159_CR20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/chemse\/bjm058","volume":"33","author":"J Loetsch","year":"2008","unstructured":"Loetsch J, Reichmann H, Hummel T. Different odor tests contribute differently to the evaluation of olfactory loss. Chem Senses 2008, 33: 17\u201321.","journal-title":"Chem Senses"},{"key":"159_CR21","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1212\/WNL.49.5.1424","volume":"49","author":"S Barz","year":"1997","unstructured":"Barz S, Hummel T, Pauli E, Majer M, Lang CJ, Kobal G. Chemosensory event-related potentials in response to trigeminal and olfactory stimulation in idiopathic Parkinson\u2019s disease. Neurology 1997, 49: 1424\u20131431.","journal-title":"Neurology"},{"key":"159_CR22","first-page":"47","volume":"14","author":"T Hummel","year":"1999","unstructured":"Hummel T. Olfactory evoked potentials as a tool to measure progression of Parkinson\u2019s disease. Focus Med 1999, 14: 47\u201353.","journal-title":"Focus Med"},{"key":"159_CR23","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00415-008-0665-5","volume":"255","author":"B Herting","year":"2008","unstructured":"Herting B, Schulze S, Reichmann H, Haehner A, Hummel T. A longitudinal study of olfactory function in patients with idiopathic Parkinson\u2019s disease. J Neurol 2008, 255: 367\u2013370.","journal-title":"J Neurol"},{"key":"159_CR24","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/mds.10713","volume":"19","author":"E Huisman","year":"2004","unstructured":"Huisman E, Uylings HB, Hoogland PV. A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson\u2019s disease. Mov Disord 2004, 19: 687\u2013692.","journal-title":"Mov Disord"},{"key":"159_CR25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.expneurol.2005.08.028","volume":"197","author":"B Winner","year":"2006","unstructured":"Winner B, Geyer M, Couillard-Despres S, Aigner R, Bogdahn U, Aigner L, et al. Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb. Exp Neurol 2006, 197: 113\u2013121.","journal-title":"Exp Neurol"},{"key":"159_CR26","first-page":"99","volume":"13","author":"J Roth","year":"1998","unstructured":"Roth J, Radil T, Ruzickas E, Jech R, Tich\u00fd J. Apomorphine does not influence olfactory thresholds in Parkinson\u2019s disease. Funct Neurol 1998, 13: 99\u2013103.","journal-title":"Funct Neurol"},{"key":"159_CR27","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1002\/mds.25661","volume":"28","author":"A Haehner","year":"2013","unstructured":"Haehner A, Hummel T, Wolz M, Klingelh\u00f6fer L, Fauser M, Storch A, et al. Effects of rasagiline on olfactory function in patients with Parkinson\u2019s disease. Mov Disord 2013, 28: 2023\u20132027.","journal-title":"Mov Disord"},{"key":"159_CR28","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00702-015-1433-1","volume":"122","author":"A Haehner","year":"2015","unstructured":"Haehner A, Habersack A, Wienecke M, Storch A, Reichmann H, Hummel T. Early Parkinson\u2019s disease patients on rasagiline present with better odor discrimination. J Neural Transm 2015, 122: 1541\u20131546.","journal-title":"J Neural Transm"},{"key":"159_CR29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mds.870100309","volume":"10","author":"RKB Pearce","year":"1995","unstructured":"Pearce RKB, Hawkes CH, Daniel SE. The anterior olfactory nucleus in Parkinson\u2019s disease. Mov Disord 1995, 10: 283\u2013287.","journal-title":"Mov Disord"},{"key":"159_CR30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 2004, 318: 121\u2013134.","journal-title":"Cell Tissue Res"},{"key":"159_CR31","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00702-005-0280-x","volume":"112","author":"A M\u00fcller","year":"2005","unstructured":"M\u00fcller A, Abolmaali N, Hakimi AR, Gloeckler T, Herting B, Reichmann H, et\u00a0al. Olfactory bulb volumes in patients with idiopathic Parkinson\u2019s disease-a pilot study. J Neural Transm 2005, 112: 1363\u20131370.","journal-title":"J Neural Transm"},{"key":"159_CR32","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1093\/brain\/awf251","volume":"125","author":"AJ Harding","year":"2002","unstructured":"Harding AJ, Stimson E, Henderson JM, Halliday GM. Clinical correlates of selective pathology in the amygdala of patients with Parkinson\u2019s disease. Brain 2002, 125: 2431\u20132445.","journal-title":"Brain"},{"key":"159_CR33","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/chemse\/28.6.537","volume":"28","author":"J Hudry","year":"2003","unstructured":"Hudry J, Thobois S, Broussolle E, Adeleine P, Royet JP. Evidence for deficiencies in perceptual and semantic olfactory processes in Parkinson\u2019s disease. Chem Senses 2003, 28: 537\u2013543.","journal-title":"Chem Senses"},{"key":"159_CR34","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00702-004-0207-y","volume":"112","author":"T Hummel","year":"2005","unstructured":"Hummel T, Jahnke U, Sommer U, Reichmann H, M\u00fcller A. Olfactory function in patients with idiopathic Parkinson\u2019s disease: effects of deep brain stimulation in the subthalamic nucleus. J Neural Transm 2005, 112: 669\u2013676.","journal-title":"J Neural Transm"},{"key":"159_CR35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-0404.1995.tb06998.x","volume":"91","author":"GK Wenning","year":"1995","unstructured":"Wenning GK, Shephard B, Hawkes C, Petruckevitch A, Lees A, Quinn N. Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand 1995, 91: 247\u2013250.","journal-title":"Acta Neurol Scand"},{"key":"159_CR36","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s007020200013","volume":"109","author":"A M\u00fcller","year":"2002","unstructured":"M\u00fcller A, Reichmann H, Livermore A, Hummel T. Olfactory function in idiopathic Parkinson\u2019s disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients. J Neural Transm 2002, 109: 805\u2013811.","journal-title":"J Neural Transm"},{"key":"159_CR37","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1054\/jocn.2001.1071","volume":"9","author":"A M\u00fcller","year":"2002","unstructured":"M\u00fcller A, M\u00fcngersdorf M, Reichmann H, Strehle G, Hummel T. Olfactory function in Parkinsonian syndromes. J Clin Neurosci 2002, 9: 521\u2013524.","journal-title":"J Clin Neurosci"},{"key":"159_CR38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40520-015-0380-x","volume":"28","author":"G Ottaviano","year":"2016","unstructured":"Ottaviano G, Frasson G, Nardello E, Martini A. Olfaction deterioration in cognitive disorders in the elderly. Aging Clin Exp Res 2016, 28: 37\u201345.","journal-title":"Aging Clin Exp Res"},{"key":"159_CR39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/s-2003-39966","volume":"30","author":"A M\u00fcller","year":"2003","unstructured":"M\u00fcller A, Abolmaali N, Hummel T, Reichmann H. Cardinal symptoms of idiopathic Parkinson disease. Akt Neurol 2003, 30: 239\u2013343.","journal-title":"Akt Neurol"},{"key":"159_CR40","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/mds.20141","volume":"19","author":"U Sommer","year":"2004","unstructured":"Sommer U, Hummel T, Cormann K, Mueller A, Frasnelli J, Kropp J, et al. Detection of presymptomatic Parkinson\u2019s disease: combination of olfactory tests, transcranial sonography, and 123-I-FP-CIT-SPECT. Mov Disord 2004, 19: 1196\u20131202.","journal-title":"Mov Disord"},{"key":"159_CR41","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1212\/WNL.45.1.182","volume":"45","author":"G Becker","year":"1995","unstructured":"Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K. Degeneration of substantia nigra in chronic Parkinson\u2019s disease visualized by transcranial color-coded real-time sonography. Neurology 1995, 45: 182\u2013184.","journal-title":"Neurology"},{"key":"159_CR42","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/archneur.59.6.999","volume":"59","author":"D Berg","year":"2002","unstructured":"Berg D, Roggendorf W, Schr\u00f6der U, Klein R, Tatschner T, Benz P, et al. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 2002, 59: 999\u20131005.","journal-title":"Arch Neurol"},{"key":"159_CR43","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/mds.21413","volume":"22","author":"A Haehner","year":"2007","unstructured":"Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H. Olfactory loss may be a first sign of idiopathic Parkinson\u2019s disease. Mov Disord 2007, 22: 839\u2013842.","journal-title":"Mov Disord"},{"key":"159_CR44","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ana.1049","volume":"50","author":"HW Berendse","year":"2001","unstructured":"Berendse HW, Booij J, Francot CM, Bergmans PL, Hijman R, Stoof, JC, et al. Subclinical dopaminergic dysfunction in asymptomatic Parkinson\u2019s disease patients\u2019 relatives with decreased sense of smell. Ann Neurol 2001, 50: 34\u201341.","journal-title":"Ann Neurol"},{"key":"159_CR45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ana.20160","volume":"56","author":"MM Ponsen","year":"2004","unstructured":"Ponsen MM, Stoffers D, Booji J, van Eck-Smit BL, Wolters EC, Berendse HW. Idiopathic hyposmia as a preclinical sign of Parkinson\u2019s disease. Ann Neurol 2004, 56: 173\u2013181.","journal-title":"Ann Neurol"},{"key":"159_CR46","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1212\/WNL.57.3.456","volume":"57","author":"RD Abbott","year":"2001","unstructured":"Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, et al. Frequency of bowel movements and the future risk of Parkinson\u2019s disease. Neurology 2001, 57: 456\u2013462.","journal-title":"Neurology"},{"key":"159_CR47","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/mds.20844","volume":"21","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson\u2019s disease: The NMSQuest study. Mov Disord 2006, 21: 916\u2013923.","journal-title":"Mov Disord"},{"key":"159_CR48","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0079-6123(10)84017-8","volume":"184","author":"KR Chaudhuri","year":"2010","unstructured":"Chaudhuri KR, Odin P. The challenge of non-motor symptoms in Parkinson\u2019s disease. Prog Brain Res 2010, 184: 325\u2013341.","journal-title":"Prog Brain Res"},{"key":"159_CR49","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1007\/s00415-012-6801-2","volume":"260","author":"MG Cersosimo","year":"2013","unstructured":"Cersosimo MG, Raina GB, Pecci C, Pellene A, Calandra CR, Guti\u00e9rrez C, et al. Gastrointestinal manifestations in Parkinson\u2019s disease: prevalence and occurrence before motor symptoms. J Neurol 2013, 260: 1332\u20131338.","journal-title":"J Neurol"},{"key":"159_CR50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","volume":"396","author":"H Braak","year":"2006","unstructured":"Braak H, de Vos RA, Bohl J, Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner\u2019s and Auerbach\u2019s plexuses in cases staged for Parkinson\u2019s disease-related brain pathology. Neurosci Lett 2006, 396: 67\u201372.","journal-title":"Neurosci Lett"},{"key":"159_CR51","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00687767","volume":"76","author":"K Wakabayashi","year":"1988","unstructured":"Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F. Parkinson\u2019s disease: the presence of Lewy bodies in Auerbach\u2019s and Meissner\u2019s plexuses. Acta Neuropathol 1988, 76: 217\u2013221.","journal-title":"Acta Neuropathol"},{"key":"159_CR52","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/mds.23838","volume":"27","author":"KM Shannon","year":"2012","unstructured":"Shannon KM, Keshavarzian A, Mutlu E, Dodiya HB, Daian D, Jaglin JA, et al. Alpha-synuclein in colonic submucosa in early untreated Parkinson\u2019s disease. Mov Disord 2012, 27: 709\u2013715.","journal-title":"Mov Disord"},{"key":"159_CR53","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/mds.25020","volume":"27","author":"KM Shannon","year":"2012","unstructured":"Shannon KM, Keshavarzian A, Dodiya HB, Jakate S, Kordower JH. Is alpha-synuclein in the colon a biomarker for premotor Parkinson\u2019s disease? Evidence from 3 cases. Mov Disord 2012, 27: 716\u2013719.","journal-title":"Mov Disord"},{"key":"159_CR54","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3233\/JPD-150680","volume":"6","author":"TG Beach","year":"2016","unstructured":"Beach TG, Adler CH, Serrano G, Sue LI, Walker DG, Dugger BN, et al. Prevalence of submandibular gland synucleinopathy in Parkinson\u2019s disease, dementia with Lewy bodies and other Lewy body disorders. J Parkinsons Dis 2016, 6: 153\u2013163.","journal-title":"J Parkinsons Dis"},{"key":"159_CR55","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.nbd.2011.08.014","volume":"45","author":"H Pouclet","year":"2012","unstructured":"Pouclet H, Lebouvier T, Coron E, Varannes SB, Rouaud T, Roy M, et al. A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson\u2019s disease. Neurobiol Dis 2012, 45: 305\u2013309.","journal-title":"Neurobiol Dis"},{"key":"159_CR56","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/mds.26480","volume":"31","author":"C Ruffmann","year":"2016","unstructured":"Ruffmann C, Parkkinen L. Gut feelings about a-synuclein in gastrointestinal biopsies: Biomarker in the making? Mov Disord 2016, 31: 193\u2013202.","journal-title":"Mov Disord"},{"key":"159_CR57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2011.04.016","volume":"310","author":"H Reichmann","year":"2011","unstructured":"Reichmann H. View point: etiology in Parkinson\u2019s disease. Dual hit or spreading intoxication. J Neurol Sci 2011, 310: 9\u201311.","journal-title":"J Neurol Sci"},{"key":"159_CR58","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1289\/ehp.0900852","volume":"117","author":"NM Gatto","year":"2009","unstructured":"Gatto NM, Cockburn M, Bornstein J, Manthripragada AD, Ritz B. Well-water consumption and Parkinson\u2019s disease in rural California. Environ Health Perspect 2009, 117: 1912\u20131918.","journal-title":"Environ Health Perspect"},{"key":"159_CR59","first-page":"49","volume":"100","author":"JW Langston","year":"1984","unstructured":"Langston JW, Langston EB, Irwin I. MPTP-induced parkinsonism in human and non-human primates-clinical and experimental aspects. Acta Neurol Scand Suppl 1984, 100: 49\u201354.","journal-title":"Acta Neurol Scand Suppl"},{"key":"159_CR60","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mds.26069","volume":"30","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, et al. Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov Disord 2015, 30: 350\u2013358.","journal-title":"Mov Disord"},{"key":"159_CR61","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/mds.25882","volume":"29","author":"P Derkinderen","year":"2014","unstructured":"Derkinderen P, Shannon KM, Brundin P. Gut feelings about smoking and coffee in Parkinson\u2019s disease. Mov Disord 2014, 29: 976\u2013979.","journal-title":"Mov Disord"},{"key":"159_CR62","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/jamaneurol.2014.4563","volume":"72","author":"MJ Howell","year":"2015","unstructured":"Howell MJ, Schenck CH. Rapid eye movement sleep behavior disorder and neurodegenerative disease. JAMA Neurol 2015, 72: 707\u2013712.","journal-title":"JAMA Neurol"},{"key":"159_CR63","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.neurol.2016.07.001","volume":"172","author":"A Elbaz","year":"2016","unstructured":"Elbaz A. Prodromal symptoms of Parkinson\u2019s disease: Implications for epidemiological studies of disease etiology. Rev Neurol (Paris) 2016, 172: 503\u2013511.","journal-title":"Rev Neurol (Paris)"},{"key":"159_CR64","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1474-4422(06)70476-8","volume":"5","author":"A Iranzo","year":"2006","unstructured":"Iranzo A, Molinuevo JL, Santamaria J, Serradell M, Mart\u00ed MJ, Valldeoriola F, et al. Rapid-eye-movement sleep behavior disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 2006, 5: 572\u2013577.","journal-title":"Lancet Neurol"},{"key":"159_CR65","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1353-8020(13)00400-8","volume":"20","author":"RB Postuma","year":"2014","unstructured":"Postuma RB. Prodromal Parkinson\u2019s disease-using REM sleep behavior disorder as a window. Parkinsonism Relat Disord 2014, 20: S1\u2013S4.","journal-title":"Parkinsonism Relat Disord"},{"key":"159_CR66","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/brain\/awh322","volume":"128","author":"K Stiasny-Kolster","year":"2005","unstructured":"Stiasny-Kolster K, Doerr Y, M\u00f6ller JC, H\u00f6ffken H, Behr TM, Oertel WH, et al. Combination of \u201cidiopathic\u201d REM sleep behavior disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 2005, 128: 126\u2013137.","journal-title":"Brain"},{"key":"159_CR67","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1212\/WNL.0000000000001265","volume":"84","author":"P Mahlknecht","year":"2015","unstructured":"Mahlknecht P, Iranzo A, H\u00f6gl B, Frauscher B, M\u00fcller C, Santamar\u00eda J, et al. Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD. Neurology 2015, 84: 654\u2013658.","journal-title":"Neurology"},{"key":"159_CR68","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/mds.26055","volume":"29","author":"A Iranzo","year":"2014","unstructured":"Iranzo A, Stockner H, Serradell M, Seppi K, Valldeoriola F, Frauscher B, et al. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder. Mov Disord 2014, 29: 1774\u20131780.","journal-title":"Mov Disord"},{"key":"159_CR69","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1007\/s00415-015-7742-3","volume":"262","author":"C Aquirre-Mardones","year":"2015","unstructured":"Aquirre-Mardones C, Iranzo A, Vilas D, Serradell M, Gaig C, Santamar\u00eda J, et al. Prevalence and timeline of nonmotor symptoms in idiopathic rapid eye movement sleep behavior disorder. J Neurol 2015, 262: 1568\u20131578.","journal-title":"J Neurol"},{"key":"159_CR70","doi-asserted-by":"crossref","unstructured":"Heller J, Brcina N, Dogan I, Holtbernd F, Romanzetti S, Schulz JB, et al. Brain imaging findings in idiopathic REM sleep behavior disorder (RBD)\u2014A systematic review on potential biomarkers for neurodegeneration. Sleep Med. Rev 2016.","DOI":"10.1016\/j.smrv.2016.06.006"},{"key":"159_CR71","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1212\/WNL.0000000000002126","volume":"85","author":"FS Sprenger","year":"2015","unstructured":"Sprenger FS, Stefanova N, Gelpi E, Seppi K, Navarro-Otano J, Offner F, et al. Enteric nervous system a-synuclein immunoreactivity in idiopathic REM sleep behavior disorder. Neurology 2015, 85: 1761\u20131768.","journal-title":"Neurology"},{"key":"159_CR72","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.parkreldis.2016.06.003","volume":"29","author":"W Schrempf","year":"2016","unstructured":"Schrempf W, Katona I, Dogan I, Felbert VV, Wienecke M, Heller J, et al. Reduced intraepidermal nerve fiber density in patients with REM sleep behavior disorder. Parkinsonism Relat Disord 2016, 29: 10\u201316.","journal-title":"Parkinsonism Relat Disord"},{"key":"159_CR73","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.5665\/sleep.6102","volume":"39","author":"F Sixel-D\u00f6ring","year":"2016","unstructured":"Sixel-D\u00f6ring F, Zimmermann J, Wegener A, Mollenhauer B, Trenkwalder C. The evolution of REM sleep behavior disorder in early Parkinson disease. Sleep 2016, 39: 1737\u20131742.","journal-title":"Sleep"},{"key":"159_CR74","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1212\/WNL.0000000000002651","volume":"87","author":"B Mollenhauer","year":"2016","unstructured":"Mollenhauer B, Zimmermann J, Sixel-D\u00f6ring F, Focke NK, Wicke T, Ebentheuer J, et al. Monitoring of 30 marker candidates in early Parkinson disease as progression markers. Neurology 2016, 87: 168\u2013177.","journal-title":"Neurology"},{"key":"159_CR75","doi-asserted-by":"crossref","unstructured":"Kang SH, Lee HM, Seo WK, Kim JH, Koh SB. The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson\u2019s disease. J Neurol Sci 368: 374\u2013378.","DOI":"10.1016\/j.jns.2016.07.057"},{"key":"159_CR76","doi-asserted-by":"crossref","first-page":"e0160199","DOI":"10.1371\/journal.pone.0160199","volume":"11","author":"SF Huang","year":"2016","unstructured":"Huang SF, Chen K, Wu JJ, Liu FT, Zhao J, Lin W, et al. Odor identification test in idiopathic REM-behavior disorder and Parkinson\u2019s disease in China. PLoS One 2016, 11: e0160199.","journal-title":"PLoS One"},{"key":"159_CR77","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.sleep.2015.12.020","volume":"21","author":"SX Li","year":"2016","unstructured":"Li SX, Lam SP, Zhang J, Yu MW, Chan JW, Liu Y, et al. A prospective, naturalistic follow-up study of treatment outcomes with clonazepam in rapid eye movement sleep behavior disorder. Sleep Med 2016, 21: 114\u2013120.","journal-title":"Sleep Med"},{"key":"159_CR78","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.5664\/jcsm.6200","volume":"12","author":"Y Wang","year":"2016","unstructured":"Wang Y, Yang Y, Wu H, Lan D, Chen Y, Zhao Z. Effects of rotigotine on REM sleep behavior disorder in Parkinson disease. J Clin Sleep Med 2016, 12:1403\u20131409.","journal-title":"J Clin Sleep Med"},{"key":"159_CR79","unstructured":"Arnaldi D, Antelmi E, St. Louis EK, Postuma RB, Arnulf I. Idiopathic REM sleep behavior disorder and neurodegenerative risk: To tell or not to tell to the patient? How to minimize the risk? Sleep Med Rev 2016, pii: S1087-0792(16)30131-9."},{"key":"159_CR80","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00415-010-5465-z","volume":"257","author":"O Riedel","year":"2010","unstructured":"Riedel O, Lotsche J, Spottke A, Deuschl G, F\u00f6rstl H, Henn F, et al. Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson\u2019s disease. J Neurol 2010, 257: 1073\u20131082.","journal-title":"J Neurol"},{"key":"159_CR81","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/WNL.58.10.1501","volume":"58","author":"AG Schuurman","year":"2002","unstructured":"Schuurman AG, Van den Akker M, Ensinck KT, Metsemakers JF, Knottnerus JA, Leentjens AF, et al. Increased risk of Parkinson\u2019s disease after depression: a retrospective cohort study. Neurology 2002, 58: 1501\u20131504.","journal-title":"Neurology"},{"key":"159_CR82","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jamaneurol.2014.2950","volume":"72","author":"M Beavan","year":"2015","unstructured":"Beavan M, McNeill A, Proukakis C, Hughes DA, Mehta A, Schapira AH. Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort. JAMA Neurol 2015, 72: 201\u2013208.","journal-title":"JAMA Neurol"},{"key":"159_CR83","doi-asserted-by":"crossref","first-page":"e108982","DOI":"10.1371\/journal.pone.0108982","volume":"9","author":"C Gaig","year":"2014","unstructured":"Gaig C, Vilas D, Infante J, Sierra M, Garc\u00eda-Gorostiaga I, Buongiorno M, et al. Nonmotor symptoms in LRRK2 G20195 associated Parkinson\u2019s disease. PLoS One 2014, 9: e108982.","journal-title":"PLoS One"},{"key":"159_CR84","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/mds.10387","volume":"18","author":"AF Leentjens","year":"2003","unstructured":"Leentjens AF, Van den Akker M, Metsemakers JF, Lousberg R, Verhey FR. Higher incidence of depression preceding the onset of Parkinson\u2019s disease: a register study. Mov Disord 2003, 18: 414\u2013418.","journal-title":"Mov Disord"},{"key":"159_CR85","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.parkreldis.2010.06.014","volume":"16","author":"EI Jacob","year":"2010","unstructured":"Jacob EI, Gatto NM, Thompson A, Bordelon Y, Ritz B. Occurrence of depression and anxiety prior to Parkinson\u2019s disease. Park Relat Disord 2010, 16: 576\u2013581.","journal-title":"Park Relat Disord"},{"key":"159_CR86","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1474-4422(14)70287-X","volume":"14","author":"A Schrag","year":"2015","unstructured":"Schrag A, Horsfall L, Walters K, Noyce A, Petersen I. Prediagnostic presentations of Parkinson\u2019s disease in primary care: a case-control study. Lancet Neurol 2015, 14: 57\u201364.","journal-title":"Lancet Neurol"},{"key":"159_CR87","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/gps.1456","volume":"21","author":"U Ehrt","year":"2006","unstructured":"Ehrt U, Bronnick K, Leentjens AF, Larsen JP, Aarsland D. Depressive symptom profile in Parkinson\u2019s disease: a comparison with depression in elderly patients without Parkinson\u2019s disease. Int J Geriatr Psychiatry 2006, 21: 252\u2013258.","journal-title":"Int J Geriatr Psychiatry"},{"key":"159_CR88","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/jnnp.2010.213652","volume":"82","author":"RG Brown","year":"2011","unstructured":"Brown RG, Landau S, Hindle JV, Playfer J, Samuel M, Wilson KC, et al. Depression and anxiety related subtypes in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 2011, 82: 803\u2013809.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12264-017-0159-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-017-0159-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-017-0159-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:07:06Z","timestamp":1569974826000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12264-017-0159-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,3]]},"references-count":88,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["159"],"URL":"https:\/\/doi.org\/10.1007\/s12264-017-0159-5","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,3]]}}}